about
Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features.Attenuation of miR-126 activity expands HSC in vivo without exhaustion.Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice.
P50
description
researcher, ORCID id # 0000-0002-5916-8516
@en
wetenschapper
@nl
name
Massimo Saini
@ast
Massimo Saini
@en
Massimo Saini
@es
Massimo Saini
@nl
type
label
Massimo Saini
@ast
Massimo Saini
@en
Massimo Saini
@es
Massimo Saini
@nl
prefLabel
Massimo Saini
@ast
Massimo Saini
@en
Massimo Saini
@es
Massimo Saini
@nl
P106
P31
P496
0000-0002-5916-8516